ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Insulin glargine
C267H404N72O78S6
6063 g/mol
APIWarning

Insulin glargine

CAS160337-95-1
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Insulin glargine is a long-acting insulin analog used as a pharmaceutical raw material in the manufacturing of insulin products. It is a large, flexible polypeptide with a complex structure characterized by multiple disulfide bridges and extensive hydrogen-bonding capacity.

pharmaceutical raw material for insulin analog formulations

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 160337-95-1

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongStructure SimilarSimilarity 0.96

Exubera

CAS11061-68-0

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.93

Insulin degludec

CAS844439-96-9

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.93

Insulin detemir

CAS169148-63-4

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.85

Insulin, neutral

CAS12584-58-6

pharmaceutical raw material

ReferenceSame Category

L-Carnitine orotate

CAS160468-17-7

pharmaceutical raw material

ReferenceSame Category

Isosorbide mononitrate

CAS16051-77-7

pharmaceutical raw material

ReferenceSame Category

Gatifloxacin hydrochloride

CAS160738-57-8

pharmaceutical raw material

ReferenceSame Category

Faricimab

CAS1607793-29-2

pharmaceutical raw material

Safety Reference

Health Hazard
Health Hazard
Warning
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name

(4S)-4-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-47-(carboxymethylcarbamoyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[(2S)-2-[[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid

InChIKey

COCFEDIXXNGUNL-RFKWWTKHSA-N

SMILES

CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NCC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N[C@@H](CC7=CC=C(C=C7)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N8CCC[C@H]8C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CO)[C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CN

Synonyms (54)
  • 901, HOE
  • Abasaglar
  • Abasaglar kwikpen
  • BASAGLAR KwikPen
  • BASAGLAR Tempo Pen
  • Basaglar
  • Glargin
  • Glargine
  • Glargine, Insulin
  • Glargine-aglr, Insulin
  • HOE 71GT
  • Ins lantus
  • Ins lantus opticlik
  • Ins lantus optiset
  • Ins lantus solostar
  • Insulin 1556
  • Insulin Glargine (>90%)
  • Insulin Glargine Solostar
  • Insulin Glargine recombinant
  • Insulin glargine
  • Insulin glargine CRS
  • Insulin glargine U-300
  • Insulin glargine U-300 Max
  • Insulin glargine-yfgn
  • Insulina glargina
  • Lantus
  • Lantus R
  • Lantus Solostar
  • Lusduna
  • Lusduna Nexvue
  • Optisulin
  • REZVOGLAR KWIKPEN
  • Rezvoglar
  • Semglee
  • SoloStar
  • Solostar, Lantus
  • TOUJEO MAX SOLOSTAR
  • TOUJEO Max
  • Toujeo
  • Toujeo Solostar
  • insulin glargin
  • insuline glargine
  • insulinum glarginum